FSTL1 and pulmonary fibrosis: Targeting FSTL1 with a specific antibody in vivo ameliorated bleomycin-induced lung fibrosis in mice, similar to FSTL1 genetic insufficiency in transgenic mice heterozygous for the FSTL1 knockout allele [26].